MRO Magazine

Research and Markets: Opportunities in the Indian API Market


October 21, 2015
By Business Wire News

DUBLIN

Research and Markets (http://www.researchandmarkets.com/research/8xs4x3/opportunities_in) has announced the addition of the “Opportunities in the Indian API Market” report to their offering.

The Indian API market is likely to show a promising growth in the coming years. The Indian API market is forecasted to grow at a CAGR of 13% from 2014-2020.

India, being the third largest API market in the Asia-Pacific region, has been gaining a lot of attention worldwide since the last few years. The accelerated growth of the Indian API market can be attributed to the increased efforts being made by the Indian government to improve the infrastructure of the API industry and provide maximum support to domestic API manufacturers. This is being done, so that India does not have to depend on other countries for the import of APIs. Indian API manufacturers are also trying to strengthen their hold of the regulated markets by various means. A major competitor for India in this field is China, which provides APIs at very low rates. However, all the hard work being put in by the API manufacturers and government will help India to become the top API market not only in Asia-Pacific, but also in the world.

In the report Opportunities in Indian API Market, the analysts have addressed the current scenario of the Indian API market, major drivers of the market, and factors hindering the growth of the market. Apart from this, the segmentation of the market by various parameters, such as type of manufacture, type of drug, type of API and type of therapeutic area, has also been specified. The important mergers and acquisitions in the Indian API market have also been mentioned in the report. Various initiatives taken by the government to promote the Indian API industry have been listed down. Owing to the various government initiatives, such as the declaration of 2015 as the Year of APIs, Make in India campaign, etc., the Indian API market is likely to show a promising growth in the coming years. The Indian API market is forecasted to grow at a CAGR of 13% from 2014-2020.

The report also mentions the key players in the Indian API Market. For every player, a brief business overview, geographic revenue break-up, and segment-wise revenue break-up has been provided. A strength and weakness analysis of every player has also been presented to assist the investors in developing an understanding of the strategies of major players. A separate section has been provided in the report for the opportunities and recommendations for the development of the Indian API market. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the Indian API market.

Key Topics Covered:

1. Analyst View

2. Research Methodology

3. India API Industry Outlook

4. Drivers & Challenges

5. Market Segmentation

6. Mergers and Acquisitions

7. Government Initiatives

8. Regulatory Scenario

9. Competitive Landscape

10. Future Outlook

11. Opportunities and Recommendations

Companies Mentioned

– Aurobindo Pharma Limited

– Biocon

– Cipla Limited

– Dr. Reddy’s Laboratories

– Glenmark

– Jubilant LifeSciences

– Lupin Ltd.

– Sun Pharma

– Wockhardt

– Zydus Cadila

For more information visit http://www.researchandmarkets.com/research/8xs4x3/opportunities_in.

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals